Page last updated: 2024-10-18

imidazole and Nasopharyngeal Carcinoma

imidazole has been researched along with Nasopharyngeal Carcinoma in 1 studies

imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.

Nasopharyngeal Carcinoma: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wu, Q1
Song, Y1
Liu, R1
Wang, R1
Mei, W1
Chen, W1
Yang, H1
Wang, X1

Other Studies

1 other study available for imidazole and Nasopharyngeal Carcinoma

ArticleYear
Synthesis, docking studies and antitumor activity of phenanthroimidazole derivatives as promising c-myc G-quadruplex DNA stabilizers.
    Bioorganic chemistry, 2020, Volume: 102

    Topics: Animals; Antineoplastic Agents; DNA; G-Quadruplexes; Humans; Imidazoles; Molecular Docking Simulatio

2020